Zhengyuan Xia, Ph.D.
Affiliations: | 2004 | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
Pathology, Medicine and Surgery, PharmacologyGoogle:
"Zhengyuan Xia"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jiang Y, Cai Y, Han R, et al. (2024) Salvianolic acids and its potential for cardio-protection against myocardial ischemic reperfusion injury in diabetes. Frontiers in Endocrinology. 14: 1322474 |
Wang R, Dong S, Xia R, et al. (2023) Kinsenoside mitigates myocardial ischemia/reperfusion-induced ferroptosis via activation of the Akt/Nrf2/HO-1 pathway. European Journal of Pharmacology. 956: 175985 |
Zhang X, Wang C, Xu H, et al. (2023) Propofol inhibits myocardial injury induced by microvesicles derived from hypoxia-reoxygenated endothelial cells via lncCCT4-2/CCT4 signaling. Biological Research. 56: 20 |
Sun M, Wang R, Xia R, et al. (2022) Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine. Frontiers in Pharmacology. 13: 949754 |
Han RH, Huang HM, Han H, et al. (2021) Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia. Military Medical Research. 8: 58 |
Zeng F, Luo J, Han H, et al. (2021) Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2. International Journal of Immunopathology and Pharmacology. 35: 20587384211031417 |
Wang S, Ge L, Zhang D, et al. (2020) MiR-181c-5p Promotes Inflammatory Response during Hypoxia/Reoxygenation Injury by Downregulating Protein Tyrosine Phosphatase Nonreceptor Type 4 in H9C2 Cardiomyocytes. Oxidative Medicine and Cellular Longevity. 2020: 7913418 |
Peng K, Liu H, Yan B, et al. (2020) Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis. Journal of Cellular Physiology |
Yan D, Cai Y, Luo J, et al. (2020) FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes. Journal of Cellular and Molecular Medicine |
Wang C, Yuan W, Hu A, et al. (2020) Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury. Molecular Medicine Reports |